pargyline has been researched along with Alloxan Diabetes in 9 studies
Pargyline: A monoamine oxidase inhibitor with antihypertensive properties.
| Excerpt | Relevance | Reference |
|---|---|---|
| "In recent years the effect of experimental diabetes mellitus on brain neurochemistry has been under an intensive investigation." | 1.28 | Streptozotocin and alloxan produce alterations in rat brain monoamines independently of pancreatic beta cells destruction. ( Lacković, Z; Salković, M, 1990) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 7 (77.78) | 18.7374 |
| 1990's | 1 (11.11) | 18.2507 |
| 2000's | 1 (11.11) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Visentin, V | 1 |
| Bour, S | 1 |
| Boucher, J | 1 |
| Prévot, D | 1 |
| Valet, P | 1 |
| Ordener, C | 1 |
| Parini, A | 1 |
| Carpéné, C | 1 |
| Crandall, EA | 1 |
| Gillis, MA | 1 |
| Fernstrom, JD | 1 |
| Smith, SA | 2 |
| Pogson, CL | 1 |
| Marston, FA | 1 |
| Dickson, AJ | 1 |
| Pogson, CI | 1 |
| Lacković, Z | 1 |
| Salković, M | 1 |
| Trulson, ME | 1 |
| Jacoby, JH | 1 |
| MacKenzie, RG | 1 |
| Nishibori, M | 1 |
| Oishi, R | 1 |
| Itoh, Y | 1 |
| Saeki, K | 1 |
| Schwab, E | 1 |
| Burkart, V | 1 |
| Freytag, G | 1 |
| Kiesel, U | 1 |
| Kolb, H | 1 |
| Lundquist, I | 1 |
| Ekholm, R | 1 |
| Ericson, LE | 1 |
9 other studies available for pargyline and Alloxan Diabetes
| Article | Year |
|---|---|
Glucose handling in streptozotocin-induced diabetic rats is improved by tyramine but not by the amine oxidase inhibitor semicarbazide.
Topics: Adipocytes; Adipose Tissue; Amine Oxidase (Copper-Containing); Animals; Benzylamines; Blood Glucose; | 2005 |
Reduction in brain serotonin synthesis rate in streptozotocin-diabetic rats.
Topics: Animals; Brain; Diabetes Mellitus, Experimental; Hydroxyindoleacetic Acid; Kinetics; Male; Pargyline | 1981 |
Tryptophan and the control of plasma glucose concentrations in the rat.
Topics: 5-Hydroxytryptophan; Adrenalectomy; Animals; Blood Glucose; Diabetes Mellitus, Experimental; Fenclon | 1977 |
Control of enzyme activities in rat liver by tryptophan and its metabolites.
Topics: Adrenalectomy; Animals; Cycloheximide; Diabetes Mellitus, Experimental; Endotoxins; Liver; Male; Par | 1979 |
Streptozotocin and alloxan produce alterations in rat brain monoamines independently of pancreatic beta cells destruction.
Topics: Alloxan; Analysis of Variance; Animals; Biogenic Monoamines; Blood Glucose; Brain; Diabetes Mellitus | 1990 |
Streptozotocin-induced diabetes reduces brain serotonin synthesis in rats.
Topics: 5-Hydroxytryptophan; Animals; Benserazide; Brain; Carboxy-Lyases; Diabetes Mellitus, Experimental; H | 1986 |
Changes in histamine metabolism in the brains of mice with streptozotocin-induced diabetes.
Topics: Animals; Brain; Diabetes Mellitus, Experimental; Histamine; Histamine N-Methyltransferase; Histidine | 1989 |
Inhibition of immune-mediated low-dose streptozotocin diabetes by agents which reduce vascular permeability.
Topics: Animals; Blood Glucose; Capillary Permeability; Diabetes Mellitus, Experimental; Islets of Langerhan | 1986 |
Monoamines in the pancreatic islets of the mouse. 5-hydroxytryptamine as an intracellular modifier of insulin secretion, and the hypoglycaemic action of monoamine oxidase inhibitors.
Topics: 5-Hydroxytryptophan; Animals; Blood Glucose; Diabetes Mellitus, Experimental; Female; Glucose; Glybu | 1971 |